{"entity":{"type":"insider","cik":"0002030813","url":"/insider/0002030813","json_url":"/insider/0002030813.json","name":"Trimarchi Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2025-08-19","last":"2026-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Trimarchi Thomas","source":"filing","n_filings":5,"first_seen":"2025-08-19","last_seen":"2026-05-19"}],"transactions":[{"id":5844504,"accession":"0001470831-26-000473","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001470831-26-000473","line_url":"/filing/0001470831-26-000473","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002030813","owner_name":"Trimarchi Thomas","owner_display_name":"Trimarchi Thomas","owner_url":"/insider/0002030813","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13651.0,"shares_display":"13,651","price_per_share":65.08088580323786,"price_display":"65.08","price_state":"stated","total_value":888419.1721,"total_display":"888,419.17","total_whole":"888,419","shares_owned_after":362389.0,"shares_owned_after_display":"362,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-19","scope":"insider","n_lines":2},{"id":6054019,"accession":"0001470831-26-000184","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001470831-26-000184","line_url":"/filing/0001470831-26-000184","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002030813","owner_name":"Trimarchi Thomas","owner_display_name":"Trimarchi Thomas","owner_url":"/insider/0002030813","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13600.0,"shares_display":"13,600","price_per_share":74.7167,"price_display":"74.72","price_state":"stated","total_value":1016147.12,"total_display":"1,016,147.12","total_whole":"1,016,147","shares_owned_after":336785.0,"shares_owned_after_display":"336,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-18","scope":"insider","n_lines":2},{"id":4471929,"accession":"0001470831-25-000351","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001470831-25-000351","line_url":"/filing/0001470831-25-000351","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002030813","owner_name":"Trimarchi Thomas","owner_display_name":"Trimarchi Thomas","owner_url":"/insider/0002030813","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16934.0,"shares_display":"16,934","price_per_share":66.45827437108775,"price_display":"66.46","price_state":"stated","total_value":1125404.4182,"total_display":"1,125,404.42","total_whole":"1,125,404","shares_owned_after":389786.0,"shares_owned_after_display":"389,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider","n_lines":2},{"id":4342176,"accession":"0000950170-25-111011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-111011","line_url":"/filing/0000950170-25-111011#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002030813","owner_name":"Trimarchi Thomas","owner_display_name":"Trimarchi Thomas","owner_url":"/insider/0002030813","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42237.0,"shares_display":"42,237","price_per_share":49.4846,"price_display":"49.48","price_state":"stated","total_value":2090081.0502,"total_display":"2,090,081.05","total_whole":"2,090,081","shares_owned_after":421081.0,"shares_owned_after_display":"421,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":5034268,"accession":"0000950170-25-110274","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-110274","line_url":"/filing/0000950170-25-110274","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002030813","owner_name":"Trimarchi Thomas","owner_display_name":"Trimarchi Thomas","owner_url":"/insider/0002030813","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17353.0,"shares_display":"17,353","price_per_share":50.23468107531839,"price_display":"50.23","price_state":"stated","total_value":871722.4207,"total_display":"871,722.42","total_whole":"871,722","shares_owned_after":465291.0,"shares_owned_after_display":"465,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Officer (President and CFO)","n_filings":5,"first_seen":"2025-08-19","last_seen":"2026-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002030813","retrieved_at":"2026-08-27T09:09:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}